Grants 2016-2017

Duerfeldt, Adam, Harold Hamm Oklahoma Diabetes Center, Hit to Lead Optimization of a Novel PPAR Agonist towards a Systemically Available Treatment for Diabetic Retinopathy, 1/1/2017 – 6/30/2017, $50,000

Gappa-Fahlenkamp, Heather, Oklahoma Center for Adult Stem Cell Research, Using a Tissue-Engineered Vascular Model to Develop Mast Cells from Adult Stem Cells, 07/01/16 – 06/30/17, $103,826

Gappa-Fahlenkamp, Heather, Oklahoma Center for the Advancement of Science and Technology, Ex Vivo Generation of Dendritic Cells from an Advanced Vascular Tissue Construct, 07/01/16 - 06/30/19, $135,000

Kovats, Susan, and Gappa-Fahlenkamp, Heather, Oklahoma Center for Adult Stem Cell Research, Differentiation of human hematopoietic stem cells to lung resident immune cells in a tissue-engineered lung model, 01/01/17 - 12/31/18, $78,098 (Total $156,196)

Ford Versypt, Ashlee Oklahoma Center for the Advancement of Science and Technology, Computational Modeling of the Onset of Diabetic Kidney Disease, 10/01/2017 – 9/30/2020, $135,000

Lacombe, Veronique, NIH, The SERCA pump as a major regulator of glucose metabolism. 12/2016-06/2017, $50,000

Lacombe, Veronique, Oklahoma Agricultural Experiment Station, USDA, Proteoglycans and insulin resistance: novel mechanisms. 12/2016-12/2017, $25,000

Li, Shitao, NIH/NIAID 1R15AI126360-01A1, Taxilin alpha regulates DNA-mediated and interferon-dependent innate immunity. 02/06/2017-01/31/2020, $431,815

Li, Shitao, NIH/NIAID R01AI121288, Interferon-induced IFITM recruitment of ZMPSTE24 blocks viral endocytic entry, 7/1/2016 - 6/30/2020, $813,488

Li, Shitao, Oklahoma Center for the Advancement of Science and Technology, Role of Plakophilin 2 in Limiting Influenza A Virus Infection, 10/01/2017 – 9/30/2020, $135,000

Lin,Daniel, Oklahoma Center for the Advancement of Science and Technology, Beta beta carotene 9' 10' -oxygenase 2 in acute respiratory distress syndrome, 10/01/2017 – 9/30/2020, $135,000

McFarlane, Dianne, Oklahoma Agricultural Research Station, USDA. Targeted thermosensitive nanoparticle therapy for the treatment of equine endocrinopathic laminitis, 2016-2017, $25,000

McFarlane, Dianne, Research Advisory Committee, Center for Veterinary Health Sciences, Oklahoma State University, Whole genome sequencing to identify genetic risk factors for pituitary pars intermedia dysfunction (PPID) and PPID-associated laminitis. 2016 - 2017, $20,000. 

Miller, Kenneth, Oklahoma Center for the Advancement of Science and Technology, The role of glutamatergic sensory neurons in the initiation of and response to colitis. 08/01/16-07/31/2019, $135,000

Narasaraju,Telugu, Oklahoma Center for the Advancement of Science and Technology, A novel therapy for influenza pneumonia. 09/2016 - 08/2019, $135,000                           

Oomens, Antonius, NIH/NIAID 1R21AI28520-01A1, A self-limited live RSV vaccine inducing anti- pre-fusion F antibodies. 01/25/2017 - 12/31/2018, $357,172

Patrauchan, Marianna  and Lutter, Erika, NIH R15, Ca2+-binding protein EfhP mediates Ca2+ regulation of Pseudomonas aeruginosa virulence and host-pathogen interactions, $448,800, 07/01/2017-06/30/2018

Ranjan, Ashish, Oklahoma Center for the Advancement of Science and Technology, Magnetic hyperthermia combined antimicrobial targeting of bone pathogens, 10/01/2017 – 9/30/2020, $135,000